Summit Place Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Summit Place Financial Advisors's PFE Position: Q2 2025 in Review
Summit Place Financial Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,354 shares — an estimated $237K sold.
Summit Place Financial Advisors first reported a position in PFE in Q4 2019 and held it in 22 quarters. The position peaked at $2.12M in Q4 2020. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Summit Place Financial Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Summit Place Financial Advisors sold 9,354 Pfizer shares in Q2 2025, an estimated $237K.
- Summit Place Financial Advisors first reported a position in Pfizer in Q4 2019 and held it in 22 quarters.
- Summit Place Financial Advisors's Pfizer position peaked at $2.12M in Q4 2020.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Summit Place Financial Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.